Lincoln Pharma Recommends 1.80 Rupee Dividend Per Share
Lincoln Pharmaceuticals Dividend Recommendation
Lincoln Pharmaceuticals Ltd has recommended a dividend of 1.80 rupees per share for the fiscal year 2026. The company reported a consolidated net profit of 116.3 million rupees and revenue from operations of 1.87 billion rupees for the March quarter.
Financial Performance
The company's March quarter consolidated net profit stood at 116.3 million rupees, while revenue from operations reached 1.87 billion rupees. These results are seen as positive signals for investors.
Dividend Details
The proposed dividend of 1.80 rupees per share is for the fiscal year 2026 and is subject to shareholder approval.
Impacted Symbols
Symbols affected by this headline and their sentiment signals
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.